|
|
International Biotechnology Trust PLC - Comparative Business Analysis Snapshot
Business Description
International Biotechnology Trust PLC(IBT). The Group's principal activity is that of an Investment Trust. The Group invests in companies that are undervalued, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. The objective of the Group is to achieve long term capital growth by investing in high growth, development stage biotechnology companies that are either quoted or unquoted. The Group is an Investment Company within the meaning of Section 266 of the Companies Act 1985. The Group has been approved by the HM Revenue and Customs as an Investment Trust for the purposes of Section 842 of the Income and Corporation Taxes Act 1988 for the year ended 31-Aug-2007.Investment management services are provided by SV Life Sciences Managers LLP for a fee calculated at the rate of 1.35% per annum of the Net Asset Value of the Group, payable monthly. The agreement is terminable by either party on 12 months' notice.
Competitor Analysis
This analysis compares International Biotechnology Trust PLC with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
